Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany-Reference-Cited by-同舟云学术

Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany

Published:2022-07-05 Issue:4 Volume:9 Page:597-607
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Holthuis Emily^ORCID,Smits Elisabeth^ORCID,Spentzouris George,Beier Dominik,Enders Dirk,Gini Rosa,Bartolini Claudia^ORCID,Mazzaglia Giampiero^ORCID,Penning-van Beest Fernie^ORCID,Herings Ron^ORCID

Funder

Daiichi-Sankyo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-022-00317-3.pdf

Reference31 articles.

1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–21. https://doi.org/10.1177/1747493019897870.

2. Björck S, Palaszewski B, Friberg L, et al. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44(11):3103–8. https://doi.org/10.1161/strokeaha.113.002329.

3. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–47. https://doi.org/10.1093/eurheartj/ehs253.